Antagonism of Bushen Yiqi Prescription on apoptosis of human first trimester trophoblastic cell by regulating Bcl-2 and XIAP in vitro

WANG Hai-yan,LI Xue-lian,GUI Sui-qi
2009-01-01
Abstract:Objective:To investigate the effect and mechanism of Bushen Yiqi Prescription on apoptosis of human first trimester trophoblasts.Methods:Isolated from first trimester placental tissues,human trophoblasts cultured in media with 5%, 10%,20%drug-containing serum for a 24,48 or 72h period.Then we measured cell viability by MTT assay,cell DNA content by flow cytomester,cell Caspase-3 enzyme activity by Caspase-3 active assay kit,and,cell Fas,FasL,Bcl-2 and XIAP protein.Results:Absorbency of trophoblast in 490nm wavelength increased greatly after being incubated with drug-containing serum for 24,48,and 72 h(P<0.01).Cells cultured with drug-containing serum in S phase were more and by contrast,in sub-G 1 and G 2 /M phase were less than those of control group.In addition,Caspase3 enzyme activity decreased.Also,the expression of Fas,FasL, and Bcl-2 showed dose dependent with the concentration of drug-containg serum,and it was followed with the increase of XIAP level.Conclusion:Bushen Yiqi Prescription antagonized the apoptosis of human first trimester trophoblasts by increasing the level of Bcl-2 to promote XIAP expression.Increasing of FasL expression facilitated the immunological tolerance of maternal fetal interface.
What problem does this paper attempt to address?